Skip to Main Content

Author Details

Armin Baiker
Center for Biomedical Education and Research (ZBAF), Witten/Herdecke University
1999
53
22
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37510253In Vitro Analysis of the Effect of SARS-CoV-2 Non-VOC and four Variants of Concern on MHC-Class-I Expression on Calu-3 and Caco-2 Cells.Genes (Basel)2023
34627947Detection and differentiation of murine leukemia virus (MLV) and murine stem cell virus (MSCV) and therefrom derived nucleic acids.J Virol Methods2022
35473640Replication kinetics and infectivity of SARS-CoV-2 variants of concern in common cell culture models.Virol J2022
35269463A Human In Vitro Model to Study Adenoviral Receptors and Virus Cell Interactions.Cells2022
35022408Genetic alterations of the SUMO isopeptidase SENP6 drive lymphomagenesis and genetic instability in diffuse large B-cell lymphoma.Nat Commun2022
34415422Comparison of four commercial, automated antigen tests to detect SARS-CoV-2 variants of concern.Med Microbiol Immunol2021
34576862In Vitro Rapid Antigen Test Performance with the SARS-CoV-2 Variants of Concern B.1.1.7 (Alpha), B.1.351 (Beta), P.1 (Gamma), and B.1.617.2 (Delta).Microorganisms2021
34576237Enhanced Antiviral Function of Magnesium Chloride-Modified Heparin on a Broad Spectrum of Viruses.Int J Mol Sci2021
32272960Identification of novel human adenovirus candidates using the coxsackievirus and adenovirus receptor for cell entry.Virol J2020
33087160Rapid point-of-care detection of SARS-CoV-2 using reverse transcription loop-mediated isothermal amplification (RT-LAMP).Virol J2020
31736916A Novel In-House Enzyme-Linked Immunosorbent Assay for Genotype 3 Hepatitis E Virus Reveals High Seroprevalence in Blood Donors in Northern Argentina.Front Microbiol2019
29595778Details matter for contaminants in genetic-engineering kits.Nature2018
32099171Details matter for contaminants in genetic-engineering kits.Nature2018
30006037β-Carboline derivatives as novel antivirals for herpes simplex virus.Int J Antimicrob Agents2018
28817345Reverse Transcription Quantitative Polymerase Chain Reaction for Detection of and Differentiation Between RNA and DNA of HIV-1-Based Lentiviral Vectors.Hum Gene Ther Methods2017
28725978Strategies and methods for the detection and identification of viral vectors.Virus Genes2017
25640117Standard free droplet digital polymerase chain reaction as a new tool for the quality control of high-capacity adenoviral vectors in small-scale preparations.Hum Gene Ther Methods2015
26463011The Hepatitis E virus intraviral interactome.Sci Rep2015
25859285Restitution of gene expression and histone acetylation signatures altered by hepatitis B virus through antiviral microRNA-like molecules in nontransformed murine hepatocytes.Clin Epigenetics2014
23549553A Novel Adenoviral Hybrid-vector System Carrying a Plasmid Replicon for Safe and Efficient Cell and Gene Therapeutic Applications.Mol Ther Nucleic Acids2013
23596286Comprehensive analysis of varicella-zoster virus proteins using a new monoclonal antibody collection.J Virol2013
23734827Generation of a tumor- and tissue-specific episomal non-viral vector system.BMC Biotechnol2013
23557668A novel indirect immunofluorescence test for the detection of IgG and IgA antibodies for diagnosis of Hepatitis E Virus infections.J Virol Methods2013
22130998LuMPIS: luciferase-based MBP-pull-down protein interaction screening system.Methods Mol Biol2012
22863912Serologic analysis of the IgG antibody response in children with varicella zoster virus wild-type infection and vaccination.Pediatr Infect Dis J2012
22493342Varicella zoster virus infection of malignant glioma cell cultures: a new candidate for oncolytic virotherapy?Anticancer Res2012
22661441Handling S/MAR vectors.Cold Spring Harb Protoc2012
22661432Rescue of S/MAR-containing nonviral episomal expression vectors.Cold Spring Harb Protoc2012
22661431A colony-forming assay for determining the establishment efficiency of S/MAR-containing nonviral episomal expression vectors.Cold Spring Harb Protoc2012
22269698Systematic screening for novel, serologically reactive Hepatitis E Virus epitopes.Virol J2012
22428977Universal real-time PCR for the detection and quantification of adeno-associated virus serotype 2-derived inverted terminal repeat sequences.Hum Gene Ther Methods2012
21304940Entrapment of viral capsids in nuclear PML cages is an intrinsic antiviral host defense against varicella-zoster virus.PLoS Pathog2011
21988664Varicella zoster virus ORF25 gene product: an essential hub protein linking encapsidation proteins and the nuclear egress complex.J Proteome Res2011
20080061A staining control for the HCMV pp65 antigen test.J Clin Virol2010
20514382Systematic analysis of the IgG antibody immune response against varicella zoster virus (VZV) using a self-assembled protein microarray.Mol Biosyst2010
20646309A systematic approach for the identification of novel, serologically reactive recombinant Varicella-Zoster Virus (VZV) antigens.Virol J2010
20205920Early detection of Varicella-Zoster virus (VZV)-specific T-cells before seroconversion in primary varicella infection: case report.Virol J2010
20205919Improving the yeast two-hybrid system with permutated fusions proteins: the Varicella Zoster Virus interactome.Proteome Sci2010
20230618pEPito: a significantly improved non-viral episomal expression vector for mammalian cells.BMC Biotechnol2010
19834906LuMPIS--a modified luminescence-based mammalian interactome mapping pull-down assay for the investigation of protein-protein interactions encoded by GC-low ORFs.Proteomics2009
19730696Evolutionarily conserved herpesviral protein interaction networks.PLoS Pathog2009
18537590Episomal vectors for gene therapy.Curr Gene Ther2008
16339411Herpesviral protein networks and their interaction with the human proteome.Science2006
15795267Role of the varicella-zoster virus gene product encoded by open reading frame 35 in viral replication in vitro and in differentiated human skin and T cells in vivo.J Virol2005
15871685The nonviral episomal replicating vector pEPI-1 allows long-term inhibition of bcr-abl expression by shRNA.Hum Gene Ther2005
14722273The immediate-early 63 protein of Varicella-Zoster virus: analysis of functional domains required for replication in vitro and for T-cell and skin tropism in the SCIDhu model in vivo.J Virol2004
15272077Nuclear scaffold/matrix attached region modules linked to a transcription unit are sufficient for replication and maintenance of a mammalian episome.Proc Natl Acad Sci U S A2004
15247414Varicella-zoster virus infection of human neural cells in vivo.Proc Natl Acad Sci U S A2004
14656329VEGF is necessary for exercise-induced adult hippocampal neurogenesis.Eur J Neurosci2003
12971718Exploiting a minimal system to study the epigenetic control of DNA replication: the interplay between transcription and replication.Chromosome Res2003
  • 1 - 50 of 53

Recommended Authors

Gladstone Institutes
Career Start Year 2016
Number of shared co-authors 1
Stanford University School of Medicine
Career Start Year 2013
Number of shared co-authors 0
David Geffen School of Medicine, University of California los angeles
Career Start Year 2009
Number of shared co-authors 0
Institute of Tropical Medicine
Career Start Year 2007
Number of shared co-authors 1
Goethe University Frankfurt, University Hospital, Institute for Medical Virology
Career Start Year 2004
Number of shared co-authors 1
Texas Biomedical Research Institute
Career Start Year 2001
Number of shared co-authors 0
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year 2001
Number of shared co-authors 0
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Career Start Year 2001
Number of shared co-authors 0
Louisiana State University Health Sciences Center Shreveport
Career Start Year 2000
Number of shared co-authors 0
MRC - University of Glasgow Centre for Virus Research, University of Glasgow
Career Start Year 1998
Number of shared co-authors 1
Paul-Ehrlich-Institut
Career Start Year 1998
Number of shared co-authors 2
Gilead Sciences Inc.
Career Start Year 1997
Number of shared co-authors 1
Stanford University School of Medicine
Career Start Year 1996
Number of shared co-authors 0
University of Cambridge
Career Start Year 1996
Number of shared co-authors 1
Cancer Research Institute, Central South University
Career Start Year 1995
Number of shared co-authors 0
College of Medicine, University of Florida
Career Start Year 1994
Number of shared co-authors 0
University of California San Diego
Career Start Year 1994
Number of shared co-authors 1
University of North Carolina at Chapel Hill
Career Start Year 1993
Number of shared co-authors 0
University of Western Ontario
Career Start Year 1992
Number of shared co-authors 0
University of California los angeles
Career Start Year 1992
Number of shared co-authors 0
Institute of Virology, Philipps University Marburg
Career Start Year 1992
Number of shared co-authors 0
Fred Hutchinson Cancer Center
Career Start Year 1991
Number of shared co-authors 0
Altius Institute for Biomedical Sciences
Career Start Year 1990
Number of shared co-authors 0
Merck & Co., Inc.
Career Start Year 1989
Number of shared co-authors 2
UK System Immunity Research Institute, Cardiff University
Career Start Year 1985
Number of shared co-authors 6
Ben-Gurion University of the Negev
Career Start Year 1984
Number of shared co-authors 0
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1983
Number of shared co-authors 2
University of Texas Medical Branch
Career Start Year 1983
Number of shared co-authors 0
Rockefeller University
Career Start Year 1981
Number of shared co-authors 0
Tulane University School of Medicine
Career Start Year 1974
Number of shared co-authors 0

Collaborators

University of Edinburgh
Co-authored papers 9
University Clinic for Swine, University of Veterinary Medicine Vienna
Co-authored papers 7
Center for the Study of Biological Complexity, Virginia Commonwealth University
Co-authored papers 4
Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB
Co-authored papers 3
Oslo University Hospital
Co-authored papers 2
Co-authored papers 2
Institute of Informatics, Ludwig-Maximilians-Universitat Munchen
Co-authored papers 2
Germany Institute of Systems Biology, Shanghai University
Co-authored papers 2
Co-authored papers 2
Ludwig-Maximilians-Universitat Munchen
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 2
Max-von-Pettenkofer Institute, Ludwig-Maximilians-University (LMU) Munich
Co-authored papers 2
Saarland University
Co-authored papers 1
Massachusetts Institute of Technology
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
Stanford Center for Biomedical Informatics Research, Stanford University
Co-authored papers 1
Boehringer Ingelheim RCV GmbH & Co. KG
Co-authored papers 1
university of california los angeles
Co-authored papers 1
Institute of Pathology, University Hospital Salzburg, Paracelsus Medical University
Co-authored papers 1
Co-authored papers 1
Biodesign Institute, Arizona State University
Co-authored papers 1
Co-authored papers 1
University of California San Diego
Co-authored papers 1
Max von Pettenkofer-Institute, Ludwig-Maximilians-Universitat Munchen
Co-authored papers 1
SSSSGerman Cancer Research Center
Co-authored papers 1
Albert-Ludwigs-Universitat Freiburg, Institut fur Organische Chemie und Biochemie
Co-authored papers 1